Purchases and Sales Made in Q2 2023 in Acurx Pharmaceuticals, Inc. (ACXP)
This table provides information about the institutional ownership of Acurx Pharmaceuticals, Inc. (ACXP) during Q2 2023. The information is specifically focused on institutions that hold shares of Acurx Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
902K+ 322.14% |
$2.23M - $3.18M
|
1.18M
$1.97M
|
|
|
Aug 14, 2023
Q2 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
31.6K+ 35.27% |
$78K - $111K
|
121K
$202K
|
|
|
Aug 14, 2023
Q2 2023
|
One68 Global Capital, LLC
New York, NY |
BUY
|
- |
13KNew |
$32.2K - $46K
|
13K
$21.8K
|
|
|
Aug 10, 2023
Q2 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
6K+ 37.5% |
$14.8K - $21.2K
|
22K
$36.7K
|
|
|
Aug 11, 2023
Q2 2023
|
Black Rock Inc.
New York, NY |
BUY
|
- |
2.71K+ 16.79% |
$6.7K - $9.58K
|
18.9K
$31.5K
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
1.56K+ 53.81% |
$3.84K - $5.49K
|
4.45K
$7.42K
|
|
|
Aug 14, 2023
Q2 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
121New |
$299 - $427
|
121
$202
|
|
|
Jul 19, 2023
Q2 2023
|
Salem Investment Counselors Inc
Winston Salem, NC |
BUY
|
- |
100New |
$247 - $353
|
100
$167
|
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
3+ 4.84% |
$7.41 - $10.6
|
65
$109
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-4.74K- 21.51% |
$11.7K - $16.7K
|
17.3K
$28.9K
|